Sirolimus with Vitamin C vs. Everolimus for Heart Stents
Part of Heart & circulation clinical trials.
This trial tests whether a drug-coated heart stent (sirolimus with ascorbic acid, a form of vitamin C) works as well as another type (everolimus) for patients with blocked coronary arteries. Both drugs help prevent the stent from becoming blocked again.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have narrowed heart arteries (chronic or sudden chest pain) and need a stent procedure (PCI)
- You can take blood-thinning medications (aspirin and another drug) daily for 1 year
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have severe heart shock or life-threatening conditions that would prevent study participation
- You are willing and able to follow all study visits and instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial is testing a new stent coated with a medicine called everolimus to keep your heart arteries open. It may be an option if you have blockages that need a stent.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
This trial compares a newer type of stent (with very thin struts and a coating that dissolves) to a standard stent in people having a heart artery procedure. It aims to see if the new stent works as well or better.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.